A Study to Assess Immune Response Following Zoster Vaccination to Subjects With Rheumatoid Arthritis Receiving Tofacitinib or Placebo With Background Methotrexate
Part of paid clinical trials in Jonesboro, Arkansas.
- Sponsor
- Pfizer
- Study ID
- NCT02147587
- Phase
- PHASE2
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Tofacitinib — DRUG5 mg twice daily of tofacitinib with background methotrexate for 12 weeks
- Placebo — DRUGPlacebo tablets twice daily with background methotrexate for 12 weeks
Study Details
This study will evaluate immune response following administration of zoster vaccine in subjects with rheumatoid arthritis who are receiving background methotrexate and initiate 5 mg twice daily of tofacitinib or placebo for tofacitinib 2 to 3 weeks following vaccination.
Key Dates
- Start date
- Jun 30, 2014
- Status verified
- Mar 2018
- Primary completion
- Jun 30, 2015
- Completion
- Jul 31, 2015
Study Design
- Enrollment
- 112 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Tofacitinib 5 mg BID (oral) (70 subjects)Zoster vaccine will be administered to subjects on background methotrexate; treatment with 5 mg tofacitinib twice daily will begin 2 to 3 weeks following vaccination and continue for 12 weeks.
- Placebo Comparator: Placebo tofacitinib BID (oral) (70 subjects)Zoster vaccine will be administered to subjects on background methotrexate; treatment with placebo twice daily will begin 2 to 3 weeks following vaccination and continue for 12 weeks.
Primary Outcome Measure
Fold Change From Baseline in Varicella Zoster Virus (VZV)-Specific Immunoglobulin G (IgG) Levels at Week 4 [ Time Frame: Baseline (pre-vaccination; Day -14), Week 4 (6 weeks post-vaccination) ]
Locations (36)
Find similar trials in Jonesboro, AR
By condition
By research site
NEA Baptist Clinic· Jonesboro, ARDrug Shipping Address (IRB# 14-000826) Ronald Regan· Los Angeles, CAUCLA David Geffen School of Medicine· Los Angeles, CAPacific Arthritis Center Medical Group· Santa Maria, CAInland Rheumatology Clinical Trials, Inc.· Upland, CAJacksonville Center for Clinical Research· Jacksonville, FL
Related Studies
- Physica System Total Knee Replacement Registry StudyRecruiting · Limacorporate S.p.a · Rancho Mirage, California
- Maternal Autoimmune Disease Research Alliance (MADRA) RegistryRecruiting · Duke University · Durham, North Carolina
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPHASE1 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- RA-PRO PRAGMATIC TRIALPHASE3 · Recruiting · University of Alabama at Birmingham · Auburn, Alabama